POU4F1 promotes the resistance of melanoma to BRAF inhibitors through MEK/ERK pathway activation and MITF up-regulation.

Cell Death & Disease
Lin LiuQiong Shi

Abstract

BRAF inhibitors (BRAFi) have shown remarkable clinical efficacy in the treatment of melanoma with BRAF mutation. Nevertheless, most patients end up with the development of BRAFi resistance, which strongly limits the clinical application of these agents. POU4F1 is a stem cell-associated transcriptional factor that is highly expressed in melanoma cells and contributes to BRAF-activated malignant transformation. However, whether POU4F1 contributes to the resistance of melanoma to BRAFi remains poorly understood. Here, we report that over-expressed POU4F1 contributed to the acquired resistance of melanoma cells to Vemurafenib. Furthermore, POU4F1 promoted the activation of ERK signaling pathway via transcriptional regulation on MEK expression. In addition, POU4F1 could increase the expression of MITF to retain the resistance of melanoma cells to BRAFi. Collectively, our findings reveal that POU4F1 re-activates the MAPK pathway by transcriptional regulation on MEK expression and promotes MITF expression, which ultimately results in the resistance to BRAFi in melanoma. Our study supports that POU4F1 is a potential combined therapeutic target with BRAFi therapy for melanoma.

References

Dec 5, 1998·The International Journal of Biochemistry & Cell Biology·D S Latchman
Feb 1, 2000·Journal of Cellular Physiology·T Scholzen, J Gerdes
Mar 29, 2001·Molecular and Cellular Neurosciences·M D SmithD S Latchman
Jun 29, 2006·Annual Review of Cell and Developmental Biology·Jennifer F Crane, Paul A Trainor
Nov 15, 2007·Cell Cycle·Thomas A Khavari, John Rinn
Jun 7, 2011·The New England Journal of Medicine·Paul B ChapmanUNKNOWN BRIM-3 Study Group
Mar 6, 2012·BMC Medicine·Laura FinnRichard W Joseph
Jun 6, 2012·The New England Journal of Medicine·Keith T FlahertyUNKNOWN METRIC Study Group
Nov 24, 2012·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Patricia S NielsenTorben Steiniche
Feb 27, 2013·Clinics in Dermatology·Deborah LangChristopher R Shea
Mar 1, 2013·Proceedings of the National Academy of Sciences of the United States of America·Rizwan HaqDavid E Fisher
Mar 13, 2013·Cancer Cell·Rizwan HaqHans R Widlund
Oct 15, 2013·Pharmacology & Therapeutics·Cindy NeuzilletEric Raymond
Nov 5, 2013·Nature·Cory M JohannessenLevi A Garraway
Dec 10, 2013·European Journal of Cell Biology·Robert Besch, Carola Berking
Aug 7, 2014·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Geoffrey KimRichard Pazdur
Aug 12, 2014·Archives of Biochemistry and Biophysics·Jianglan LiuMeenhard Herlyn
Aug 22, 2014·The Journal of Investigative Dermatology·Mariusz L Hartman, Malgorzata Czyz
Sep 16, 2014·International Journal of Cancer. Journal International Du Cancer·Jacques FerlayFreddie Bray
Sep 30, 2014·The New England Journal of Medicine·Georgina V LongKeith Flaherty
Oct 8, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Douglas B JohnsonRene Gonzalez
Dec 17, 2014·Nature Communications·Judith MüllerDaniel S Peeper
Mar 20, 2015·The Journal of Investigative Dermatology·Zhenyu JiHensin Tsao
Mar 31, 2015·Pigment Cell & Melanoma Research·Claudia Wellbrock, Imanol Arozarena
Feb 2, 2016·The Journal of Investigative Dermatology·Sen GuoChunying Li
Apr 5, 2016·The Journal of Clinical Investigation·Gao ZhangMeenhard Herlyn
Feb 7, 2017·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Teresa AmaralClaus Garbe
Feb 16, 2017·Cancer Metastasis Reviews·Svenja Meierjohann
Dec 29, 2017·Molecular Cancer Therapeutics·Shanthi GaneshMarc T Abrams
Jun 16, 2018·International Journal of Cancer. Journal International Du Cancer·Laura HüserJochen Utikal
Oct 3, 2018·Pigment Cell & Melanoma Research·Michael P SmithClaudia Wellbrock
May 7, 2019·Frontiers in Oncology·Stephen A Luebker, Scott A Koepsell

❮ Previous
Next ❯

Citations

Sep 10, 2020·Biomedicines·Fleury Augustin Nsole BitegheStefan Barth
Jun 3, 2021·Life·Jiri Vachtenheim, Lubica Ondrušová

❮ Previous
Next ❯

Methods Mentioned

BETA
ChIP
protein assay
transfection
PCR
immunoprecipitation

Software Mentioned

GraphPad Prism
SPSS

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.